Mesoblast (MESO) News Today $17.23 -0.19 (-1.09%) Closing price 02/20/2025 04:00 PM EasternExtended Trading$17.32 +0.09 (+0.52%) As of 02/20/2025 06:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Mesoblast (MESO) Projected to Post Earnings on ThursdayMesoblast (NASDAQ:MESO) will be releasing earnings on Thursday, February 27. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=492137)February 20 at 1:26 AM | marketbeat.comStrategic Financial Concepts LLC Buys Shares of 138,600 Mesoblast Limited (NASDAQ:MESO)Strategic Financial Concepts LLC bought a new stake in Mesoblast Limited (NASDAQ:MESO - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 138,600 shares of the company's stock, valued at approximaFebruary 18 at 4:22 AM | marketbeat.comMesoblast: Ryoncil Approval Overshadowed By Commercial HurdlesFebruary 15, 2025 | seekingalpha.comMesoblast Limited: Ryoncil FDA Approval and Market Launch Highlighted at Tandem Transplantation MeetingsFebruary 14, 2025 | finanznachrichten.deRyoncil® FDA Approval and Market Launch Highlighted at Tandem Transplantation MeetingsFebruary 13, 2025 | globenewswire.comDomino's Pizza Enterprises And 2 Other ASX Stocks That Might Be Trading Below Fair ValueFebruary 12, 2025 | finance.yahoo.comASX companies waiting for US FDA kick-offFebruary 11, 2025 | msn.comIs Mesoblast Limited (MESO) the Best Long Term ASX Stock to Buy Now?February 11, 2025 | msn.comStrategic Financial Concepts LLC Invests $2.74 Million in Mesoblast Limited (NASDAQ:MESO)Strategic Financial Concepts LLC purchased a new stake in Mesoblast Limited (NASDAQ:MESO - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 138,600 shares of the company's stock, valFebruary 10, 2025 | marketbeat.comPiper Sandler Remains a Buy on Mesoblast (MESO)February 8, 2025 | markets.businessinsider.comMesoblast (NASDAQ:MESO) Shares Gap Up - Time to Buy?Mesoblast (NASDAQ:MESO) Shares Gap Up - Here's WhyFebruary 7, 2025 | marketbeat.comMesoblast (NASDAQ:MESO) Receives "Overweight" Rating from Piper SandlerPiper Sandler reaffirmed an "overweight" rating and set a $24.00 price objective (up from $15.00) on shares of Mesoblast in a report on Friday.February 7, 2025 | marketbeat.comWhy Block, Canyon, Fisher & Paykel Healthcare, and Mesoblast shares are falling todayFebruary 5, 2025 | msn.comMesoblast (NASDAQ:MESO) Shares Gap Down - Time to Sell?Mesoblast (NASDAQ:MESO) Shares Gap Down - Time to Sell?February 5, 2025 | marketbeat.comClayton Financial Group LLC Buys Shares of 13,893 Mesoblast Limited (NASDAQ:MESO)Clayton Financial Group LLC bought a new position in Mesoblast Limited (NASDAQ:MESO - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 13,893 shares of the company's stock, valued at approximaFebruary 5, 2025 | marketbeat.comDr Boreham’s Crucible: FDA approval blasted this regenerative biotech higher in 2024… so what’s next?February 3, 2025 | msn.comMesoblast (NASDAQ:MESO) Upgraded to Strong-Buy at Cantor FitzgeraldCantor Fitzgerald raised Mesoblast to a "strong-buy" rating in a report on Thursday.February 1, 2025 | marketbeat.comIs Mesoblast Limited (MESO) One of the Best ASX Stocks to Buy According to Hedge Funds?February 1, 2025 | msn.comChronic Pain Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 20+ Companies Working in the DomainJanuary 30, 2025 | finance.yahoo.comMesoblast provides update on progress of U.S. commercial launch of RyoncilJanuary 30, 2025 | markets.businessinsider.comUp 1,090% in a year, why is the Mesoblast share price leaping higher again on Friday?January 30, 2025 | msn.comRyoncil® Commercial Launch Update and Product PipelineJanuary 30, 2025 | globenewswire.comAppendix 4C Quarterly Activity Report for Quarter Ended December 31, 2024January 30, 2025 | globenewswire.com$1,000 invested in Mesoblast shares at the start of 2024 is now worth…January 30, 2025 | msn.comMesoblast Limited (NASDAQ:MESO) Holdings Decreased by Penbrook Management LLCPenbrook Management LLC trimmed its position in Mesoblast Limited (NASDAQ:MESO - Free Report) by 15.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 91,075 shares of the company's stock after selling 16,200 shares during tJanuary 30, 2025 | marketbeat.comMesoblast (NASDAQ:MESO) Trading Up 4.8% - Here's WhyMesoblast (NASDAQ:MESO) Trading Up 4.8% - Time to Buy?January 29, 2025 | marketbeat.comWhy Mesoblast (MESO) Is Among the Best Australian Stocks to Buy Now?January 27, 2025 | msn.comMesoblast (NASDAQ:MESO) Shares Gap Down - Here's WhyMesoblast (NASDAQ:MESO) Shares Gap Down - Here's What HappenedJanuary 24, 2025 | marketbeat.comCantor Fitzgerald Predicts Mesoblast FY2025 EarningsMesoblast Limited (NASDAQ:MESO - Free Report) - Equities researchers at Cantor Fitzgerald issued their FY2025 earnings estimates for Mesoblast in a note issued to investors on Tuesday, January 21st. Cantor Fitzgerald analyst L. Chen anticipates that the company will earn ($0.70) per share for theJanuary 23, 2025 | marketbeat.comUp 19% in a month, what's driving Mesoblast shares?January 21, 2025 | msn.comMesoblast (NASDAQ:MESO) Shares Gap Up - Should You Buy?Mesoblast (NASDAQ:MESO) Shares Gap Up - Here's What HappenedJanuary 21, 2025 | marketbeat.comMesoblast shares dip then flip on $800,000 insider buyJanuary 21, 2025 | msn.comMesoblast Limited (NASDAQ:MESO) Short Interest UpdateMesoblast Limited (NASDAQ:MESO - Get Free Report) saw a significant growth in short interest during the month of December. As of December 31st, there was short interest totalling 1,800,000 shares, a growth of 34.3% from the December 15th total of 1,340,000 shares. Based on an average daily volume of 384,900 shares, the days-to-cover ratio is presently 4.7 days.January 16, 2025 | marketbeat.comFirst FDA-Approved Mesenchymal Stromal Cell Therapy Ushers in a New Era of Regenerative MedicineJanuary 16, 2025 | tmcnet.comMesoblast (NASDAQ:MESO) Trading Down 2.2% - Here's WhyMesoblast (NASDAQ:MESO) Shares Down 2.2% - Should You Sell?January 15, 2025 | marketbeat.comMesoblast (NASDAQ:MESO) Shares Gap Down - Here's What HappenedMesoblast (NASDAQ:MESO) Shares Gap Down - Here's WhyJanuary 14, 2025 | marketbeat.comStocks making the biggest moves at noon: Telix, Mesoblast, Uranium and moreJanuary 13, 2025 | msn.comHealth Check: Mesoblast shares sink despite $260m placementJanuary 13, 2025 | msn.comMesoblast (NASDAQ:MESO) Sees Strong Trading Volume - Should You Buy?Mesoblast (NASDAQ:MESO) Sees Unusually-High Trading Volume - Still a Buy?January 10, 2025 | marketbeat.comHotCopper users flock to make sense of darling Mesoblast's 'proposed financing'January 10, 2025 | msn.comWhy are Mesoblast shares in a trading halt?January 10, 2025 | msn.comMesoblast (NASDAQ:MESO) Trading Down 3.4% - Here's WhyMesoblast (NASDAQ:MESO) Trading Down 3.4% - What's Next?January 7, 2025 | marketbeat.comUp 77% in a month! What's going on with the Mesoblast share price?January 7, 2025 | fool.com.auJane Street Group LLC Has $695,000 Position in Mesoblast Limited (NASDAQ:MESO)Jane Street Group LLC raised its stake in shares of Mesoblast Limited (NASDAQ:MESO - Free Report) by 46.4% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 85,102 shares of the company's stock after acquiring an additional 26,959 shares durinJanuary 4, 2025 | marketbeat.comWhy Appen, Brainchip, Liontown, and Mesoblast shares are falling todayJanuary 2, 2025 | msn.comMesoblast (NASDAQ:MESO) Shares Gap Up - Still a Buy?Mesoblast (NASDAQ:MESO) Shares Gap Up - Should You Buy?January 2, 2025 | marketbeat.comWhy Brainchip, Fortescue, Mesoblast, and QBE shares are racing higher todayJanuary 1, 2025 | msn.comMesoblast After Approval: Stock Is Buoyant Now, But Unpredictable OverallDecember 30, 2024 | seekingalpha.comMesoblast (NASDAQ:MESO) Reaches New 52-Week High - Time to Buy?Mesoblast (NASDAQ:MESO) Reaches New 1-Year High - What's Next?December 30, 2024 | marketbeat.comMesoblast (NASDAQ:MESO) Trading Down 5.7% - What's Next?Mesoblast (NASDAQ:MESO) Shares Down 5.7% - What's Next?December 27, 2024 | marketbeat.com Get Mesoblast News Delivered to You Automatically Sign up to receive the latest news and ratings for MESO and its competitors with MarketBeat's FREE daily newsletter. Email Address MESO Media Mentions By Week MESO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MESO News Sentiment▼0.680.60▲Average Medical News Sentiment MESO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MESO Articles This Week▼44▲MESO Articles Average Week Get Mesoblast News Delivered to You Automatically Sign up to receive the latest news and ratings for MESO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies QGEN News Today ASND News Today ROIV News Today RVMD News Today LEGN News Today BBIO News Today AXSM News Today BPMC News Today TLX News Today ELAN News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MESO) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredNvidia > DeepSeekEveryone's getting it all wrong … Sure, DeepSeek's reveal caused AI stocks to tumble … But, in the long ...Weiss Ratings | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mesoblast Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Mesoblast With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
